Ken Tait
@kiffty
Followers
2K
Following
16K
Media
821
Statuses
35K
Helping people & Businesses with their problems/issues through Hypno-psycotherapy, Coaching/Mentoring & Consultancy, Diabetes Advocate & DEEP member
Bromley
Joined July 2011
Helping people with their emotional problems through #therapy & #counselling 07967807654 or email kftait@btinternet.com #Anxiety #depression #stress #diabetes #T1D #T2D
1
6
10
💙 IDF Europe is delighted to participate in the @EUCVHAlliance CVD Summit, highlighting the close link between CVD and diabetes. Kostas Tagkalos, a T2D advocate, will share his lived experience, discussing the need for more joined-up, person-centred policies across Europe.
1
1
1
Umbrella review of 432 RCTs shows GLP-1RAs reduce risks of HF 💙, PAD 🦵, kidney outcomes 💚, weight ⚖️ and HbA1c 🔬 With no increase in cancer risk. https://t.co/1rW9W5XDrP
1
18
71
📊 Young-Onset Hypertension in Type 2 Diabetes 🕑 Young-onset HTN (YOH): <45 years Compared with matched T2D controls- ⬆️ risk of ❤️ Cardiovascular Disease 🧠 Heart Failure 🗂️ Chronic Kidney Disease ⚰️ All-Cause Death ♀️ Women affected more → greater excess risk for CVD &
2
12
35
Menopause isn’t just a reproductive milestone — it’s a metabolic one. Shifting hormones can impact weight, glucose, and how medications work for women with #diabetes. Read Karen Graffeo’s lived experience + insights:
diabetessisters.org
Menopause affects how your body handles weight, glucose, and medications — but it’s not a setback; it’s the start of a wiser, more informed chapter in living well with diabetes.
0
1
2
Pharmacological therapies for type 2 diabetes: future approaches 🔬 The future of diabetes treatment is multi-targeted. Despite 9 existing drug classes, many with T2D fail to reach durable glycaemic control. Emerging non-insulin agents—notably incretin and amylin
3
55
167
We’re into the final few days of this @UlsterUniLHS survey of #menopause & #diabetes It would be amazing to have more responses from those living with #T2D, those from #SouthEastAsian and #BlackTwitter communities and those in Scotland & Wales https://t.co/qJpeMcLJk4
0
2
1
Important field safety notice from @FreeStyleLibre about Libre 3 / 3+ that can give false low readings Patients are instructed to visit https://t.co/suXvNVFKdX to determine if they have any affected sensors @DSNforumUK @DTN_UK @ABCDiab @theGBDOC @TIME_research @WilmotEmma
freestylecheck.com
0
19
25
🧠💉 SGLT2 inhibitors associated with cardiovascular benefit even in people with diabetes + dementia In a population-based target trial ➡️ SGLT2i vs DPP4i cut all-cause death or CV hospitalisation in those with dementia (NNT = 20). ➡️ Also reduced mortality & heart failure
0
21
68
Tomorrow's #DiabetesChat 🎧💬🎙️💙 🗓️ 3rd November ⏰ 8pm-10pm GMT 🫂 Hosts: @Kes_t1D_SW & @KirstyFrancais
#DiabetesAwarenessMonth
https://t.co/84xEOST70Z
0
8
7